Drug trial results show that vaccines aren’t the only use for the mRNA technology behind the most widely used COVID-19 jabs. Drug trial results show that vaccines aren't the only use for the mRNA technology behind the most widely used COVID-19 jabs.
The commercial success of RNA vaccines for COVID-19 has revved up interest in circular RNAs as the next generation of therapies. The commercial success of RNA vaccines for COVID-19 has revved up interest in circular RNAs as the next generation of therapies.